We are live on ! Find out more
ENZN

ENZON PHARMACEUTICALS INC
ENZN

Delisted

ENZN was delisted on the 19th of May, 2016.

Back to rankings

79 hedge funds and large institutions have $34.2M invested in ENZON PHARMACEUTICALS INC in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 33 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 82 → 79 (-3)

19% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 16

39% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 33

40% less capital invested

Capital invested by funds: $57.1M → $34.2M (-$22.9M)

Holders
79
Holders Change
-3
Holders Change %
-3.66%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
20
Reduced
33
Closed
16
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
+$22K

Top Buyers

Rank Fund Capital Flow
1
PAMU
Pictet Asset Management (UK)
United Kingdom
+$487K
2
BIT
BlackRock Institutional Trust
California
+$376K
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$309K
4
Goldman Sachs
Goldman Sachs
New York
+$268K
5
State Street
State Street
Massachusetts
+$238K

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$5.16M
2
BFA
BlackRock Fund Advisors
California
-$793K
3
BCM
Bridgeway Capital Management
Texas
-$427K
4
HMC
Harbert Management Corporation
Alabama
-$406K
5
Charles Schwab
Charles Schwab
California
-$368K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$193K – – –
PAM
27
Panagora Asset Management
Massachusetts
$176K -$2.93K -1,900 -1%
BIM
28
BlackRock Investment Management
Delaware
$153K -$5.81K -3,775 -3%
Acadian Asset Management
29
Acadian Asset Management
Massachusetts
$151K -$55.4K -35,942 -22%
BIM
30
Bogle Investment Management
Massachusetts
$149K – – –
Citadel Advisors
31
Citadel Advisors
Florida
$148K -$193K -125,252 -50%
AG
32
Algert Global
California
$145K – – –
Two Sigma Advisers
33
Two Sigma Advisers
New York
$140K +$22.3K +14,477 +14%
SIM
34
Spark Investment Management
New York
$127K -$29.7K -19,300 -15%
GC
35
Globeflex Capital
California
$117K – – –
Invesco
36
Invesco
Georgia
$114K -$199K -129,320 -57%
Los Angeles Capital Management
37
Los Angeles Capital Management
California
$100K +$16.2K +10,510 +14%
Charles Schwab
38
Charles Schwab
California
$92K -$368K -238,920 -75%
BJ
39
BlackRock Japan
Japan
$85K +$2.9K +1,884 +3%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$78K – – –
WMSA
41
Weiss Multi-Strategy Advisers
New York
$78K +$103K +67,114 New
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$76K -$2.76K -1,790 -3%
AllianceBernstein
43
AllianceBernstein
Tennessee
$72K -$23.7K -15,400 -20%
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$68K – – –
PPA
45
Parametric Portfolio Associates
Washington
$66K -$163K -105,755 -65%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$66K -$5.08K -3,300 -5%
TA
47
Teachers Advisors
New York
$58K – – –
CS
48
Credit Suisse
Switzerland
$55K +$17.9K +11,624 +33%
FQ
49
First Quadrant
California
$54K -$2.16K -1,400 -3%
TC
50
TFS Capital
Pennsylvania
$48K -$57.6K -37,397 -48%
1
2
3 4

ENZN Hedge Fund Activity: Q4 2013 in Review

79 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q4 2013, worth a combined $34.2M — down 40% from $57.1M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ENZN and 13 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 20 added.

The largest buyer was Pictet Asset Management (UK), opening a new position worth an estimated $487K. The largest seller was Baupost Group, cutting an estimated $5.16M.

  • 79 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q4 2013, down from 82 in Q3 2013.
  • Funds reported $34.2M of ENZON PHARMACEUTICALS INC stock for Q4 2013, down 40% quarter-over-quarter.
  • 13 funds opened new ENZON PHARMACEUTICALS INC positions in Q4 2013 and 16 closed out, a net change of -3 holders.
  • The largest ENZON PHARMACEUTICALS INC buyer in Q4 2013 was Pictet Asset Management (UK), an estimated $487K added.
  • The largest ENZON PHARMACEUTICALS INC seller in Q4 2013 was Baupost Group, an estimated $5.16M sold.

Based on aggregated 13F filings for Q4 2013.